Plain-English translation of NCT05782556 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study that tracks patients who receive a transjugular intrahepatic portosystemic shunt (TIPS) — a procedure that creates a small channel inside the liver to reduce dangerous pressure buildup. Researchers are collecting detailed health information, blood samples, and follow-up data from patients before and after the procedure to understand how well it works and what side effects or complications may occur.
Many patients with advanced liver disease develop dangerously high pressure in their liver blood vessels, which can cause serious bleeding and other complications. This study exists to learn more about how this procedure helps patients, what problems might develop afterward, and which patients benefit most from the treatment.
You likely qualify if…
You likely don't qualify if…
You would enroll the day before your scheduled TIPS procedure. Researchers will collect information about your health history, take blood samples before the procedure, and gather more samples during your procedure itself. After the procedure, you'll have follow-up visits at 3, 6, and 12 months to check how you're recovering and whether any complications have developed.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Germany
Enrollment target
~2,000 participants
Started
January 2023
Primary completion
December 2033
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dominik Bettinger, MD
University Hospital Freiburg
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.